Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 52.30
+0.10 (0.19%)
Feb 10, 2026, 2:16 PM CET
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 14.06 billion as of February 10, 2026. Its market cap has decreased by -6.45% in one year.
Market Cap
14.06B
Enterprise Value
15.18B
Revenue
9.57B
Ranking
n/a
PE Ratio
17.88
Stock Price
52.30
Market Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 14.06B, an increase of 2,029.52%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 14.06B | -15.53% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 55.51B |
| Sectra AB | 40.19B |
| Elekta AB | 21.17B |
| Vitrolife AB | 12.30B |
| MedCap AB | 8.20B |
| Xvivo Perfusion AB | 6.33B |
| CellaVision AB | 3.89B |
| BICO Group AB | 1.23B |